Neurolymphomatosis - diagnosis and assessment of treatment response by FDG PET-CT

被引：26
|
作者：
Lin, M. [1 ,2 ]
Kilanowska, J. [3 ]
Taper, J. [3 ]
Chu, J. [1 ,2 ]
机构：
[1] Liverpool Hosp, Dept Nucl Med, Sydney, NSW 2170, Australia
[2] Liverpool Hosp, PET, Sydney, NSW 2170, Australia
[3] Nepean Canc Care Ctr, Penrith, NSW 2750, Australia
来源：
HEMATOLOGICAL ONCOLOGY | 2008年 / 26卷 / 01期
关键词：
neurolymphomatosis; NHL; FDG; PET; response;
D O I：
10.1002/hon.837
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Neurolymphomatosis (NL) is lymphomatous infiltration of peripheral nerves, and is an uncommon manifestation of non-Hodgkin's lymphoma (NHL). Although nerve biopsy is the main method for histological diagnosis, a blind nerve biopsy may not be diagnostic. While CT and MRI have been used to detect NL, recent reports demonstrated the benefit of integrated positron emission tomography (PET) using F-18-2-fluoro-2-deoxy-D-glucose (FDG) combined with computed tomography (CT). We described the utility of FDG PET-CT in this uncommon subgroup of NHL where it can assist in establishing the diagnosis, the potential to guide sites for biopsy and in the assessment of response to therapy. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码：43 / 45
页数：3
相关论文
共 50 条
  • [1] Neurolymphomatosis: Diagnosis of extension and assessment of response to treatment with PET-CT
    Duran, C.
    Infante, J. R.
    Serrano, J.
    Rayo, J. I.
    Garcia, L.
    Dominguez, M. L.
    Sanchez, R.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2009, 28 (06): : 295 - 298
  • [2] Neurolymphomatosis Diagnosed by 18F-FDG PET-CT
    Salm, Liesbeth P.
    Van der Hiel, Bernies
    Stokkel, Marcel P. M.
    [J]. CLINICAL NUCLEAR MEDICINE, 2013, 38 (06) : E261 - E262
  • [3] Neurolymphomatosis on 18F-FDG PET/CT Diagnosis and Therapy Response
    Gykiere, Pieterjan
    Jans, Lennart
    Degrieck, Bert
    Goethals, Ingeborg
    [J]. CLINICAL NUCLEAR MEDICINE, 2016, 41 (02) : 142 - 143
  • [4] PET-CT to diagnose neurolymphomatosis
    Ros-Castello, V.
    Gomez-Lopez, A.
    Chico, J. L.
    Sanchez-Sanchez, A.
    Natera-Villalba, E.
    Buisan, J.
    Garcia-Barragan, N.
    Corral Corral, I.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 909 - 909
  • [5] FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes
    Davidson, Tima
    Kedmi, Meirav
    Avigdor, Abraham
    Komisar, Orna
    Chikman, Bar
    Lidar, Merav
    Goshen, Elinor
    Zwas, S. Tzila
    Ben-Haim, Simona
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (02) : 348 - 356
  • [6] FDG PET/CT in Neurolymphomatosis
    Soni, Neetu
    Ora, Manish
    [J]. RADIOLOGY, 2021, 298 (01) : 36 - 36
  • [7] Diagnosis of neurolymphomatosis with FDG PET
    Rosso, Sonja M.
    de Bruin, Hein G.
    Wu, Ka Lung
    van den Bent, Martin J.
    [J]. NEUROLOGY, 2006, 67 (04) : 722 - 723
  • [8] PET-CT for treatment response assessment in lymphoma
    Stroobants, S.
    Brepoels, L.
    Thomas, J.
    Verhoef, G.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 20 - 20
  • [9] Fusion PET-CT imaging of neurolymphomatosis
    Trojan, A
    Jermann, M
    Taverna, C
    Hany, TF
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (05) : 802 - 805
  • [10] PET-CT in radiation oncology - The impact on diagnosis, treatment planning, and assessment of treatment response
    Heron, Dwight E.
    Andrade, Regiane S.
    Beriwal, Sushil
    Smith, Ryan P.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (04): : 352 - 362
12345